Hsbc Holdings PLC Logic Bio Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.35 - $0.74 $3,879 - $8,202	-11,085 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $2,392 - $9,765	-3,922 Reduced 26.13%	11,085 $8,000
Q2 2021 Aug 13, 2021	BUY	$4.03 - $7.57 $12 - $22	3 Added 0.02%	15,007 $66,000
Q1 2021 May 14, 2021	SELL	$6.8 - $9.16 $2,665 - $3,590	-392 Reduced 2.55%	15,004 $109,000
Q4 2020 Feb 12, 2021	BUY	$5.29 - $9.1 $81,444 - $140,103	15,396 New	15,396 $117,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.